Products for patients
Ongavia (ranibizumab) is a medicine that is used in adults to treat several eye diseases causing vision impairment and is given by an ophthalmologist (eye doctor) as an injection into the eye.
The information provided on the following pages are for general purposes and aim to support the correct and safe use of Ongavia (ranibizumab). They are intended to ensure that patients and healthcare professionals are aware of and consider the requirements for the use of Ongavia.
Product-related information contained herein is subject to approval by the MHRA in the UK.
The information includes the educational material, the package leaflet and the summary of product characteristics for healthcare professionals.